| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 59.90B | 59.77B | 59.38B | 57.79B | 54.30B | 46.88B |
| Gross Profit | 33.45B | 33.02B | 31.98B | 31.48B | 31.21B | 27.25B |
| EBITDA | 17.81B | 20.30B | 19.07B | 18.98B | 17.79B | 11.56B |
| Net Income | 6.64B | 5.86B | 5.34B | 5.97B | 4.67B | 1.41B |
Balance Sheet | ||||||
| Total Assets | 211.11B | 206.64B | 219.34B | 212.94B | 217.63B | 226.41B |
| Cash, Cash Equivalents and Short-Term Investments | 7.27B | 11.39B | 10.40B | 10.07B | 12.47B | 15.56B |
| Total Debt | 75.58B | 72.17B | 78.17B | 79.99B | 88.83B | 98.56B |
| Total Liabilities | 119.69B | 117.94B | 126.66B | 128.66B | 138.29B | 148.06B |
| Stockholders Equity | 80.67B | 78.24B | 81.85B | 73.40B | 68.67B | 68.02B |
Cash Flow | ||||||
| Free Cash Flow | 11.66B | 11.19B | 8.63B | 8.14B | 9.16B | 7.11B |
| Operating Cash Flow | 15.20B | 15.05B | 13.27B | 13.30B | 14.80B | 10.89B |
| Investing Cash Flow | -3.18B | -3.26B | -4.35B | -4.62B | -5.88B | 6.34B |
| Financing Cash Flow | -12.08B | -9.85B | -8.60B | -10.62B | -11.60B | -8.47B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $40.20B | 13.94 | 15.97% | 8.22% | -0.68% | 4.29% | |
75 Outperform | $125.26B | 17.57 | 8.97% | 1.83% | -2.06% | 21.03% | |
70 Outperform | $2.46B | 17.13 | 9.07% | 2.53% | 16.59% | 1.72% | |
67 Neutral | $24.81B | 20.80 | 15.91% | 2.92% | -5.57% | 119.49% | |
65 Neutral | $21.02B | 45.73 | 5.48% | 4.33% | 1.44% | -38.87% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
53 Neutral | $9.17B | -4.33 | -17.66% | 4.08% | -4.01% | -339.22% |